Me (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic ...

Me is considering a sale of the company as it weighs up strategic options, capping a torrid year for the genetic testing ...

Founded in 2006, 23andMe seized consumer interest with its genetic-testing kits that offered customers breakdowns of their ancestry. In 2017, it started selling tests designed to help assess a ...

with the goal of recruiting 10,000 adults who have been diagnosed with lung cancer in the US who will receive 23andMe kits at no cost. It is being funded by Troper Wojcicki Philanthropies.

At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.

By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...

Company Notes Continued Concerns Regarding Liquidity and Consideration of Potential Ways to Address Operational and Financial ...

23andMe is considering a sale of the company ... “Experts point out that DNA testing kits are mostly a one-time purchase, limiting long-term revenue. Additionally, despite possessing one of ...